Hoanh Tran

Hoanh Tran

Auto-generated profile, based on publicly available information

Hoanh Tran

Ubiquitin Signalling Division, Walter and Eliza Hall Institute of Medical Research

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
BTBang Manh Tran
Bang Manh Tran
DFDustin Flanagan
Dustin Flanagan
GEGregor Ebert
Gregor Ebert
NWNadia Warner
Nadia Warner
HTHoanh Tran
Hoanh Tran
Elizabeth VincanElizabeth Vincan
Elizabeth Vincan
An emerging theme for Wnt-addicted cancers is that the pathway is regulated at multiple steps via various mechanisms. Infection with hepatitis B virus (HBV) is a major risk factor for liver cancer, as is deregulated Wnt signaling, however, the interaction between these two causes is poorly understood. To investigate this interaction, we screened the effect of the various HBV proteins for their effect on Wnt/β-catenin signaling and identified the pre-core protein p22 as a novel and potent activator of TCF/β-catenin transcription. The effect of p22 on TCF/β-catenin transcription was dose dependent and inhibited by dominant-negative TCF4. HBV p22 activated synthetic and native Wnt target gene promoter reporters, and TCF/β-catenin target gene expression in vivo. Importantly, HBV p22 activated Wnt signaling on its own and in addition to Wnt or β-catenin induced Wnt signaling. Furthermore, HBV p22 elevated TCF/β-catenin transcription above constitutive activation in colon cancer cells due to mutations in downstream genes of the Wnt pathway, namely APC and CTNNB1. Collectively, our data identifies a previously unappreciated role for the HBV pre-core protein p22 in elevating Wnt signaling. Understanding the molecular mechanisms of p22 activity will provide insight into how Wnt signaling is fine-tuned in cancer.


3 April 2023
Verified
Other
Open access
LTLars Tögel
Lars Tögel
RNRebecca Nightingale
Rebecca Nightingale
ACAnderly Chueh
Anderly Chueh
AJAparna Jayachandran
Aparna Jayachandran
HTHoanh Tran
Hoanh Tran
JMJohn Mariadason
John Mariadason
BET protein expression in primary colorectal cancers.

3 April 2023
Verified
Other
Open access
LTLars Tögel
Lars Tögel
RNRebecca Nightingale
Rebecca Nightingale
ACAnderly Chueh
Anderly Chueh
AJAparna Jayachandran
Aparna Jayachandran
HTHoanh Tran
Hoanh Tran
JMJohn Mariadason
John Mariadason
BET protein expression in 20 colon cancer cell lines.

3 April 2023
Verified
Other
Open access
LTLars Tögel
Lars Tögel
RNRebecca Nightingale
Rebecca Nightingale
ACAnderly Chueh
Anderly Chueh
AJAparna Jayachandran
Aparna Jayachandran
HTHoanh Tran
Hoanh Tran
JMJohn Mariadason
John Mariadason
Genotypes of colorectal cancer cell lines.

15 December 2023 in eLife
Verified
Journal Article
Open access
DFDaniel Frank
Daniel Frank
MBMaria Bergamasco
Maria Bergamasco
MMMichael J Mlodzianoski
Michael J Mlodzianoski
AKAndrew Kueh
Andrew Kueh
ETEllen Tsui
Ellen Tsui
HTHoanh Tran
Hoanh Tran
ZRANB1 (human Trabid) missense mutations have been identified in children diagnosed with a range of congenital disorders including reduced brain size, but how Trabid regulates neurodevelopment is not understood. We have characterized these patient mutations in cells and mice to identify a key role for Trabid in the regulation of neurite growth. One of the patient mutations flanked the catalytic cysteine of Trabid and its deubiquitylating (DUB) activity was abrogated. The second variant retained DUB activity, but failed to bind STRIPAK, a large multiprotein assembly implicated in cytoskeleton organization and neural development. Zranb1 knock-in mice harboring either of these patient mutations exhibited reduced neuronal and glial cell densities in the brain and a motor deficit consistent with fewer dopaminergic neurons and projections. Mechanistically, both DUB-impaired and STRIPAK-binding-deficient Trabid variants impeded the trafficking of adenomatous polyposis coli (APC) to microtubule plus-ends. Consequently, the formation of neuronal growth cones and the trajectory of neurite outgrowth from mutant midbrain progenitors were severely compromised. We propose that STRIPAK recruits Trabid to deubiquitylate APC, and that in cells with mutant Trabid, APC becomes hyperubiquitylated and mislocalized causing impaired organization of the cytoskeleton that underlie the neuronal and developmental phenotypes.